A recent trial showed its new 2-for-1 injection was more effective on both illnesses than existing individual shots.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
The regulator sees some patents as ploys to keep companies from developing cheaper generic versions of 20 different brand-name drugs.
The clock is ticking on TikTok. Or is it? And if it is, whose hand is on the alarm setting as of this morning?
The chip giant’s patent history signals its ideas for the future of the data center.
‘We rushed into the cloud. It’s not necessarily the answer.’